한국어
English
日本語
中文(简体)
Viralto Capsule 75 mg (Encorafenib)
75mg
Hard capsule · Prescription medication
Korean Ono Pharmaceutical Co., Ltd.
Encorafenib is an anticancer ingredient that inhibits the growth of malignant tumor cells.
MFDS ingredient code M281291
Encorafenib is an anticancer agent that targets the abnormally activated BRAF protein in specific cancer cells. This ingredient is primarily used for the treatment of certain malignant tumors such as skin cancer. It shows therapeutic effects by preventing the proliferation of cancer cells.
Encorafenib blocks the activity of the BRAF protein within cancer cells, disrupting the signals for cell division. As a result, cancer cells can no longer proliferate rapidly. Consequently, tumor growth is suppressed.
Approved uses differ by product. Check each product's information for its actual use.
Encorafenib has high selectivity among BRAF inhibitors, reducing its impact on normal cells while acting specifically on cancer cells. The therapeutic effect may be enhanced when used in combination with other BRAF inhibitors. This ingredient is used in a personalized manner for cancers with specific genetic mutations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.